Connor, Clark & Lunn Investment Management (CC&L)’s Sangamo Therapeutics SGMO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-349,894
| Closed | -$1.1M | – | 1432 |
|
2022
Q4 | $1.1M | Sell |
349,894
-255,044
| -42% | -$801K | 0.01% | 679 |
|
2022
Q3 | $2.96M | Buy |
604,938
+218,812
| +57% | +$1.07M | 0.02% | 419 |
|
2022
Q2 | $1.6M | Buy |
386,126
+271,712
| +237% | +$1.13M | 0.01% | 515 |
|
2022
Q1 | $665K | Sell |
114,414
-24,745
| -18% | -$144K | ﹤0.01% | 729 |
|
2021
Q4 | $1.04M | Sell |
139,159
-150,869
| -52% | -$1.13M | 0.01% | 672 |
|
2021
Q3 | $2.61M | Buy |
290,028
+105,116
| +57% | +$947K | 0.01% | 468 |
|
2021
Q2 | $2.21M | Buy |
184,912
+94,506
| +105% | +$1.13M | 0.01% | 518 |
|
2021
Q1 | $1.13M | Sell |
90,406
-46,857
| -34% | -$587K | 0.01% | 672 |
|
2020
Q4 | $2.14M | Buy |
137,263
+119,470
| +671% | +$1.86M | 0.01% | 498 |
|
2020
Q3 | $168K | Buy |
+17,793
| New | +$168K | ﹤0.01% | 852 |
|
2017
Q2 | – | Sell |
-55,509
| Closed | -$289K | – | 930 |
|
2017
Q1 | $289K | Sell |
55,509
-1,700
| -3% | -$8.85K | ﹤0.01% | 733 |
|
2016
Q4 | $174K | Sell |
57,209
-12,900
| -18% | -$39.2K | ﹤0.01% | 805 |
|
2016
Q3 | $325K | Sell |
70,109
-93,600
| -57% | -$434K | ﹤0.01% | 658 |
|
2016
Q2 | $948K | Sell |
163,709
-123,100
| -43% | -$713K | 0.01% | 477 |
|
2016
Q1 | $1.74M | Sell |
286,809
-70,700
| -20% | -$428K | 0.01% | 355 |
|
2015
Q4 | $3.26M | Buy |
357,509
+74,625
| +26% | +$681K | 0.03% | 268 |
|
2015
Q3 | $1.6M | Buy |
282,884
+179,312
| +173% | +$1.01M | 0.01% | 330 |
|
2015
Q2 | $1.15M | Sell |
103,572
-23,100
| -18% | -$256K | 0.01% | 314 |
|
2015
Q1 | $1.99M | Sell |
126,672
-10,500
| -8% | -$165K | 0.02% | 234 |
|
2014
Q4 | $2.09M | Buy |
137,172
+88,672
| +183% | +$1.35M | 0.02% | 219 |
|
2014
Q3 | $523K | Buy |
+48,500
| New | +$523K | ﹤0.01% | 382 |
|
2014
Q2 | – | Sell |
-53,400
| Closed | -$1.07M | – | 620 |
|
2014
Q1 | $1.07M | Buy |
53,400
+35,600
| +200% | +$711K | 0.01% | 371 |
|
2013
Q4 | $263K | Sell |
17,800
-25,100
| -59% | -$371K | ﹤0.01% | 624 |
|
2013
Q3 | $463K | Buy |
42,900
+18,700
| +77% | +$202K | ﹤0.01% | 376 |
|
2013
Q2 | $199K | Buy |
+24,200
| New | +$199K | ﹤0.01% | 474 |
|